Virally targeted therapies for EBV-associated malignancies
- 11 August 2003
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 22 (33) , 5122-5130
- https://doi.org/10.1038/sj.onc.1206548
Abstract
In Epstein–Barr virus (EBV)-positive lymphomas, the presence of the EBV genome in virtually all tumor cells, but very few normal cells, suggests that novel, EBV-targeted therapies could be used to treat these malignancies. In this paper, we review a variety of different approaches currently under development that specifically target EBV-infected cells for destruction. EBV-based strategies for treating cancer include prevention of viral oncogene expression, inducing loss of the EBV episome, the purposeful induction of the lytic form of EBV infection, and enhancing the host immune response to virally encoded antigens.Keywords
This publication has 103 references indexed in Scilit:
- A replica exchange Monte Carlo algorithm for protein folding in the HP modelBMC Bioinformatics, 2007
- Reduced models of proteins and their applicationsPolymer, 2004
- Long proteins with unique optimal foldings in the H-P modelComputational Geometry, 2003
- Activators of the Epstein-Barr Virus Lytic Program Concomitantly Induce Apoptosis, but Lytic Gene Expression Protects from Cell DeathJournal of Virology, 2001
- Identification of a Novel Element Involved in Regulation of the Lytic Switch BZLF1 Gene Promoter of Epstein-Barr VirusJournal of Virology, 2001
- Comparison of three Monte Carlo conformational search strategies for a proteinlike homopolymer model: Folding thermodynamics and identification of low-energy structuresThe Journal of Chemical Physics, 2000
- Replica-exchange molecular dynamics method for protein foldingChemical Physics Letters, 1999
- Synergistic Anticancer Effects of Ganciclovir/Thymidine Kinase and 5-Fluorocytosine/Cytosine Deaminase Gene TherapiesJNCI Journal of the National Cancer Institute, 1998
- Use of EBV-Based Vector/HVJ-Liposome Complex Vector for Targeted Gene Therapy of EBV-Associated NeoplasmsBiochemical and Biophysical Research Communications, 1997
- Effect of Herpes Simplex Virus Thymidine Kinase Expression Levels on Ganciclovir-Mediated Cytotoxicity and the “Bystander Effect”Human Gene Therapy, 1995